News
UF scientists have developed a compound that safely activates delta opioid receptors, offering pain relief without ...
Hosted on MSN9d
Novel drug compound offers safer alternative for pain relief by targeting specific receptorsIn a new study published in Nature Communications, researchers describe how this drug compound provides pain relief without ...
Zacks Investment Research on MSN13d
PCRX Doses First Patient in Phase II PCRX-201 Gene Therapy StudyPacira BioSciences PCRX announced that it has dosed the first patient in a mid-stage study of pipeline candidate PCRX-201 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback